Identification of early pericyte loss and vascular amyloidosis in Alzheimer’s disease retina H Shi, Y Koronyo, A Rentsendorj, GC Regis, J Sheyn, DT Fuchs, ... Acta Neuropathologica 139, 813-836, 2020 | 173 | 2020 |
PPARγ-coactivator-1α gene transfer reduces neuronal loss and amyloid-β generation by reducing β-secretase in an Alzheimer’s disease model L Katsouri, YM Lim, K Blondrath, I Eleftheriadou, L Lombardero, AM Birch, ... Proceedings of the National Academy of Sciences 113 (43), 12292-12297, 2016 | 154 | 2016 |
Activation of the Wnt/β‐catenin pathway represses the transcription of the β‐amyloid precursor protein cleaving enzyme (BACE1) via binding of T‐cell factor‐4 to BACE1 promoter C Parr, N Mirzaei, M Christian, M Sastre The FASEB journal 29 (2), 623-635, 2015 | 113 | 2015 |
Cascades and cognitive state: focused attention incurs subcritical dynamics ED Fagerholm, R Lorenz, G Scott, M Dinov, PJ Hellyer, N Mirzaei, ... Journal of Neuroscience 35 (11), 4626-4634, 2015 | 103 | 2015 |
Alzheimer’s retinopathy: seeing disease in the eyes N Mirzaei, H Shi, M Oviatt, J Doustar, A Rentsendorj, DT Fuchs, J Sheyn, ... Frontiers in neuroscience 14, 921, 2020 | 102 | 2020 |
In vivo imaging of microglial activation by positron emission tomography with [11C]PBR28 in the 5XFAD model of Alzheimer's disease N Mirzaei, SP Tang, S Ashworth, C Coello, C Plisson, J Passchier, ... Glia 64 (6), 993-1006, 2016 | 92 | 2016 |
Ablation of reactive astrocytes exacerbates disease pathology in a model of Alzheimer's disease L Katsouri, AM Birch, AWJ Renziehausen, C Zach, Y Aman, H Steeds, ... Glia 68 (5), 1017-1030, 2020 | 81 | 2020 |
Retinal pathological features and proteome signatures of Alzheimer’s disease Y Koronyo, A Rentsendorj, N Mirzaei, GC Regis, J Sheyn, H Shi, E Barron, ... Acta Neuropathologica 145 (4), 409-438, 2023 | 72 | 2023 |
Systemic administration of fibroblast growth factor-2 (FGF2) reduces BACE1 expression and amyloid pathology in APP23 mice L Katsouri, A Ashraf, AM Birch, KKL Lee, N Mirzaei, M Sastre Neurobiology of aging 36 (2), 821-831, 2015 | 59 | 2015 |
Retinal vasculopathy in Alzheimer’s disease H Shi, Y Koronyo, A Rentsendorj, DT Fuchs, J Sheyn, KL Black, N Mirzaei, ... Frontiers in neuroscience 15, 731614, 2021 | 52 | 2021 |
Parallels between retinal and brain pathology and response to immunotherapy in old, late‐stage Alzheimer's disease mouse models J Doustar, A Rentsendorj, T Torbati, GC Regis, DT Fuchs, J Sheyn, ... Aging Cell 19 (11), e13246, 2020 | 39 | 2020 |
Dose-dependent neuroprotection of VEGF165 in Huntington's disease striatum SM Ellison, A Trabalza, V Tisato, E Pazarentzos, S Lee, V Papadaki, ... Molecular Therapy 21 (10), 1862-1875, 2013 | 25 | 2013 |
Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid β-protein and phosphorylated tau X Du, Y Koronyo, N Mirzaei, C Yang, DT Fuchs, KL Black, ... PNAS nexus 1 (4), pgac164, 2022 | 19 | 2022 |
Imidazoline ligand BU224 reverses cognitive deficits, reduces microgliosis and enhances synaptic connectivity in a mouse model of Alzheimer's disease N Mirzaei, BC Mota, AM Birch, N Davis, C Romero‐Molina, L Katsouri, ... British Journal of Pharmacology 178 (3), 654-671, 2021 | 13 | 2021 |
Alzheimer's disease pathophysiology in the retina BP Gaire, Y Koronyo, DT Fuchs, H Shi, A Rentsendorj, R Danziger, JP Vit, ... Progress in Retinal and Eye Research 101, 101273, 2024 | 9 | 2024 |
Imaging of Microglial Activation in Alzheimer’s Disease by [11C]PBR28 PET CK Donat, N Mirzaei, SP Tang, P Edison, M Sastre Biomarkers for Alzheimer’s Disease Drug Development, 323-339, 2018 | 8 | 2018 |
Astrocyte reactivity in Alzheimer's disease: therapeutic opportunities to promote repair N Mirzaei, N Davis, TW Chau, M Sastre Current Alzheimer Research 19 (1), 1-15, 2022 | 7 | 2022 |
Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status H Shi, N Mirzaei, Y Koronyo, MR Davis, E Robinson, GM Braun, O Jallow, ... Acta Neuropathologica 148 (1), 3, 2024 | 3 | 2024 |
Identification of retinal tau oligomers, citrullinated tau, and other tau isoforms in early and advanced AD and relations to disease status H Shi, N Mirzaei, Y Koronyo, MR Davis, E Robinson, GM Braun, O Jallow, ... bioRxiv, 2024 | 2 | 2024 |
Retinal vascular abnormalities and blood‐retinal barrier breakdown in Alzheimer’s disease M Koronyo‐Hamaoui, H Shi, A Rentsendorj, DT Fuchs, J Sheyn, ... Alzheimer's & Dementia 17, e056603, 2021 | 2 | 2021 |